🇺🇸 FDA
Patent

US 9079907

Fused heterocyclic compound and use thereof

granted A61KA61K31/00A61K31/4353

Quick answer

US patent 9079907 (Fused heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/00, A61K31/4353, A61K31/553, A61P